Skip to main content
Close
Home
Society of Hospital Medicine
Presented by Society of Hospital Medicine
Home
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Michele G. Sullivan

News

Younger men and women show similar rates of osteopenia

Author:
Michele G. Sullivan
Publish date: June 4, 2019

A new study finds that about a quarter of both men and women in early middle age have osteopenia in at least one site.

  • Read More

News

Warfarin found to increase adverse outcomes among patients with IPF

Author:
Michele G. Sullivan
Publish date: May 31, 2019

DALLAS – Among patients with IPF who need anticoagulation, warfarin increased the risk of both lung transplant and death, while direct oral...

  • Read More

News

Coding variants in apolipoprotein B may be associated with early-onset Alzheimer’s disease

Author:
Michele G. Sullivan

The finding may help fill out the genetic risk picture for early-onset Alzheimer’s disease.

  • Read More

News

mTORC1 inhibitor protects elderly asthmatics from viral respiratory tract infections

Author:
Michele G. Sullivan
Publish date: May 24, 2019

DALLAS – By boosting innate immunity, RBT101 protects against rhinovirus respiratory infections and decreases the asthma exacerbations that can be...

  • Read More

News

Nintedanib cut lung function decline in interstitial lung disease with systemic sclerosis

Author:
Michele G. Sullivan
Publish date: May 20, 2019

DALLAS – A decline in FVC is a good surrogate marker of mortality in interstitial lung disease associated with...

  • Read More

News

Ultrasound offers advantages for long-term lymph node surveillance in high-grade SCC patients

Author:
Michele G. Sullivan
Publish date: May 8, 2019

BALTIMORE – Compared with other imaging modalities, ultrasound gives more anatomic details and costs much less.

  • Read More

News

Plasma levels of neurofilament light track neurodegeneration in MCI and Alzheimer’s disease

Author:
Michele G. Sullivan

The protein also may be useful to monitor effects in trials of disease-modifying drugs.

  • Read More

News

Extended half-life clotting factors cut infusions, hike prices

Author:
Michele G. Sullivan
Publish date: April 23, 2019

The use of extended half-life clotting factors was able to significantly reduce the number of infusions but the cost went up significantly.

  • Read More

News

Hip T scores can guide duration of osteoporosis therapy

Author:
Michele G. Sullivan
Publish date: April 23, 2019

A treat-to-target approach using total hip T scores could help guide decisions about how long women with osteoporosis should stay on bone-building...

  • Read More

News

Referral system aims to slash axial spondyloarthritis diagnostic delay

Author:
Michele G. Sullivan
Publish date: April 22, 2019

Canada’s community back pain clinics funnel patients with suspected axial spondyloarthritis to the...

  • Read More

News

Poor response to statins hikes risk of cardiovascular events

Author:
Michele G. Sullivan
Publish date: April 17, 2019

Patients with better outcomes were more likely to have initiated therapy with a more potent drug.

  • Read More

News

FDA orders companies to cease all sales of transvaginal mesh for POP repair

Author:
Michele G. Sullivan
Publish date: April 16, 2019

The manufacturers didn’t provide the required safety and efficacy data in their premarket applications.

  • Read More

News

BACE-1 inhibition worsens cognition in patients with prodromal Alzheimer’s disease

Author:
Michele G. Sullivan

Inhibiting the APP-cleaving enzyme decreased the toxic amyloid species, but it also worsened cognition and caused a variety of concerning adverse...

  • Read More

News

Ligelizumab maintains urticaria control for up to 1 year

Author:
Michele G. Sullivan
Publish date: April 9, 2019

WASHINGTON – The open-label extension trial found a good maintenance of effect in patients with chronic spontaneous urticaria that is...

  • Read More

News

Pembrolizumab benefits some patients with advanced cervical cancer

Author:
Michele G. Sullivan
Publish date: April 9, 2019

The checkpoint inhibitor was especially effective in patients with PD-L1-positive tumors.

  • Read More

Pages

  • « first
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • last »
An Official Publication of the Society of Hospital Medicine

Society of Hospital Medicine
Twitter Facebook LinkedIn Instagram YouTube Hospital Medicine Exchange Email RSS Feed

Copyright  © 2023 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

Menu Close